Kabiven

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, and Serine, the active ingredients in Kabiven, are an amino acid solution presented as an intravenous solution for parenteral nutrition use. It provides essential amino acids to patients who cannot receive adequate oral or enteral intake.

GNH USA supplies Kabiven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kabiven is an amino acid solution used in parenteral nutrition to meet protein and metabolic needs.

Parenteral nutrition for patients with inadequate oral or enteral intake: Supplies essential amino acids to support protein synthesis when enteral feeding is not possible. Critical care or postoperative patients: Helps meet increased protein requirements during acute illness or after surgery. Severe malnutrition: Contributes to nutritional rehabilitation by providing a balanced amino acid profile.

Kabiven may be associated with a range of infusion‑related reactions.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Electrolyte imbalance: shifts in potassium, sodium, or calcium concentrations. - Phlebitis: inflammation of the vein at the infusion site. - Infusion site reactions: redness, swelling, or discomfort.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Metabolic acidosis: significant drop in blood pH due to acid accumulation. - Hyperammonemia: elevated ammonia levels, especially in patients with hepatic impairment.

When using Kabiven, clinicians should observe several safety measures.

Renal impairment: adjust infusion volume and monitor renal function. Hepatic dysfunction: monitor ammonia and liver enzymes. Electrolyte monitoring: check serum electrolytes regularly. Hyperglycemia risk: measure blood glucose during therapy. Compatibility: ensure proper dilution and avoid mixing with incompatible solutions. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with other intravenous agents and systemic medications.

Major Interactions (Avoid): - Concurrent high‑dose potassium chloride: risk of precipitation. - Calcium‑containing solutions mixed directly: may cause insoluble calcium‑phosphate complexes. - Incompatible drugs (e.g., certain antibiotics) when combined in the same line.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase electrolyte loss. - Insulin therapy: may augment hypoglycemia risk. - Other parenteral nutrition components: monitor total nutrient and fluid load.